509 related articles for article (PubMed ID: 37298230)
1. Crosstalk of Immune Cells and Platelets in an Ovarian Cancer Microenvironment and Their Prognostic Significance.
Pankowska KA; Będkowska GE; Chociej-Stypułkowska J; Rusak M; Dąbrowska M; Osada J
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298230
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.
Ostrand-Rosenberg S; Sinha P; Beury DW; Clements VK
Semin Cancer Biol; 2012 Aug; 22(4):275-81. PubMed ID: 22313874
[TBL] [Abstract][Full Text] [Related]
3. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
Gaggero S; Witt K; Carlsten M; Mitra S
Front Immunol; 2020; 11():621225. PubMed ID: 33584718
[TBL] [Abstract][Full Text] [Related]
4. Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.
Baert T; Vankerckhoven A; Riva M; Van Hoylandt A; Thirion G; Holger G; Mathivet T; Vergote I; Coosemans A
Front Immunol; 2019; 10():1273. PubMed ID: 31214202
[TBL] [Abstract][Full Text] [Related]
5. Systemic Interleukins' Profile in Early and Advanced Colorectal Cancer.
Czajka-Francuz P; Cisoń-Jurek S; Czajka A; Kozaczka M; Wojnar J; Chudek J; Francuz T
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008550
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-Regulated Tumor-Derived Exosomes and Tumor Progression: A Focus on Immune Evasion.
Shao X; Hua S; Feng T; Ocansey DKW; Yin L
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233088
[TBL] [Abstract][Full Text] [Related]
7. The Immune Landscape in Women Cancers.
Timperi E; Vissio E; Marchiò C; Romano E
Cancer Treat Res; 2020; 180():215-249. PubMed ID: 32215872
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Associated Macrophages and Myeloid-Derived Suppressor Cells as Immunosuppressive Mechanism in Ovarian Cancer Patients: Progress and Challenges.
Okła K; Wertel I; Polak G; Surówka J; Wawruszak A; Kotarski J
Int Rev Immunol; 2016 Sep; 35(5):372-385. PubMed ID: 27644763
[TBL] [Abstract][Full Text] [Related]
10. NK Cell Interaction With Platelets and Myeloid Cells in the Tumor Milieu.
Maurer S; Ferrari de Andrade L
Front Immunol; 2020; 11():608849. PubMed ID: 33424862
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment.
Kumar V; Gabrilovich DI
Immunology; 2014 Dec; 143(4):512-9. PubMed ID: 25196648
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Dysthe M; Parihar R
Adv Exp Med Biol; 2020; 1224():117-140. PubMed ID: 32036608
[TBL] [Abstract][Full Text] [Related]
13. Myeloid regulatory cells in tumor spreading and metastasis.
Keskinov AA; Shurin MR
Immunobiology; 2015 Feb; 220(2):236-42. PubMed ID: 25178934
[TBL] [Abstract][Full Text] [Related]
14. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages.
Song M; Yeku OO; Rafiq S; Purdon T; Dong X; Zhu L; Zhang T; Wang H; Yu Z; Mai J; Shen H; Nixon B; Li M; Brentjens RJ; Ma X
Nat Commun; 2020 Dec; 11(1):6298. PubMed ID: 33293516
[TBL] [Abstract][Full Text] [Related]
15. Myeloid derived suppressor cells and innate immune system interaction in tumor microenvironment.
Pramanik A; Bhattacharyya S
Life Sci; 2022 Sep; 305():120755. PubMed ID: 35780842
[TBL] [Abstract][Full Text] [Related]
16. Revisiting macrophages in ovarian cancer microenvironment: development, function and interaction.
El-Arabey AA; Alkhalil SS; Al-Shouli ST; Awadalla ME; Alhamdi HW; Almanaa TN; Mohamed SSEM; Abdalla M
Med Oncol; 2023 Apr; 40(5):142. PubMed ID: 37039909
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH; Beury DW; Ostrand-Rosenberg S
Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
[TBL] [Abstract][Full Text] [Related]
18. Suppressing MDSC Infiltration in Tumor Microenvironment Serves as an Option for Treating Ovarian Cancer Metastasis.
Li Y; Zhang Q; Wu M; Zhang P; Huang L; Ai X; Yang Z; Shen Q; Wang Y; Wang P; Zhou S; He ML
Int J Biol Sci; 2022; 18(9):3697-3713. PubMed ID: 35813475
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Approaches Targeting the Natural Killer-Myeloid Cell Axis in the Tumor Microenvironment.
Carnevalli LS; Ghadially H; Barry ST
Front Immunol; 2021; 12():633685. PubMed ID: 33953710
[TBL] [Abstract][Full Text] [Related]
20. Synergistic COX2 Induction by IFNγ and TNFα Self-Limits Type-1 Immunity in the Human Tumor Microenvironment.
Wong JL; Obermajer N; Odunsi K; Edwards RP; Kalinski P
Cancer Immunol Res; 2016 Apr; 4(4):303-11. PubMed ID: 26817996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
